vs
Side-by-side financial comparison of Invesco Mortgage Capital Inc. (IVR) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $21.3M, roughly 1.5× Invesco Mortgage Capital Inc.). Invesco Mortgage Capital Inc. runs the higher net margin — 242.2% vs -32.1%, a 274.3% gap on every dollar of revenue. On growth, Invesco Mortgage Capital Inc. posted the faster year-over-year revenue change (55.4% vs -4.5%). Over the past eight quarters, Invesco Mortgage Capital Inc.'s revenue compounded faster (74.2% CAGR vs -0.1%).
Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
IVR vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $21.3M | $31.1M |
| Net Profit | $51.5M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | — | -9.9% |
| Net Margin | 242.2% | -32.1% |
| Revenue YoY | 55.4% | -4.5% |
| Net Profit YoY | 1368.7% | -52.0% |
| EPS (diluted) | $0.72 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.3M | — | ||
| Q3 25 | $17.6M | $31.1M | ||
| Q2 25 | $17.7M | — | ||
| Q1 25 | $18.8M | $35.2M | ||
| Q4 24 | $13.7M | $32.6M | ||
| Q3 24 | $7.5M | $24.7M | ||
| Q2 24 | $8.6M | — | ||
| Q1 24 | $7.0M | $35.7M |
| Q4 25 | $51.5M | — | ||
| Q3 25 | $53.5M | $-10.0M | ||
| Q2 25 | $-23.3M | — | ||
| Q1 25 | $19.6M | $-14.8M | ||
| Q4 24 | $3.5M | $-6.6M | ||
| Q3 24 | $40.7M | $-16.2M | ||
| Q2 24 | $-13.5M | — | ||
| Q1 24 | $29.1M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -25.7% | ||
| Q4 24 | — | -6.0% | ||
| Q3 24 | — | -46.9% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -2.5% |
| Q4 25 | 242.2% | — | ||
| Q3 25 | 303.6% | -32.1% | ||
| Q2 25 | -131.6% | — | ||
| Q1 25 | 104.4% | -42.0% | ||
| Q4 24 | 25.6% | -20.2% | ||
| Q3 24 | 542.2% | -65.7% | ||
| Q2 24 | -155.9% | — | ||
| Q1 24 | 415.9% | 43.8% |
| Q4 25 | $0.72 | — | ||
| Q3 25 | $0.74 | $-0.29 | ||
| Q2 25 | $-0.40 | — | ||
| Q1 25 | $0.26 | $-0.47 | ||
| Q4 24 | $-0.09 | $-0.25 | ||
| Q3 24 | $0.63 | $-0.53 | ||
| Q2 24 | $-0.38 | — | ||
| Q1 24 | $0.49 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $56.0M | $18.9M |
| Total DebtLower is stronger | — | $136.0M |
| Stockholders' EquityBook value | $797.5M | $-10.5M |
| Total Assets | $6.5B | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $56.0M | — | ||
| Q3 25 | $58.5M | $18.9M | ||
| Q2 25 | $59.4M | — | ||
| Q1 25 | $42.9M | $5.4M | ||
| Q4 24 | $73.4M | $9.5M | ||
| Q3 24 | $48.3M | — | ||
| Q2 24 | $58.8M | — | ||
| Q1 24 | $59.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $136.0M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $111.3M | ||
| Q3 24 | — | $106.3M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $97.1M |
| Q4 25 | $797.5M | — | ||
| Q3 25 | $769.6M | $-10.5M | ||
| Q2 25 | $709.4M | — | ||
| Q1 25 | $759.2M | $2.2M | ||
| Q4 24 | $730.7M | $15.4M | ||
| Q3 24 | $857.0M | $-3.9M | ||
| Q2 24 | $759.2M | — | ||
| Q1 24 | $785.6M | $17.7M |
| Q4 25 | $6.5B | — | ||
| Q3 25 | $6.0B | $235.2M | ||
| Q2 25 | $5.4B | — | ||
| Q1 25 | $6.2B | $237.7M | ||
| Q4 24 | $5.7B | $255.4M | ||
| Q3 24 | $6.1B | $246.8M | ||
| Q2 24 | $5.1B | — | ||
| Q1 24 | $5.2B | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $157.1M | $1.8M |
| Free Cash FlowOCF − Capex | — | $25.0K |
| FCF MarginFCF / Revenue | — | 0.1% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | 3.05× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $157.1M | — | ||
| Q3 25 | $37.3M | $1.8M | ||
| Q2 25 | $40.6M | — | ||
| Q1 25 | $19.3M | $1.2M | ||
| Q4 24 | $183.2M | $-6.1M | ||
| Q3 24 | $30.8M | $-613.0K | ||
| Q2 24 | $33.0M | — | ||
| Q1 24 | $57.5M | $-1.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | $25.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-4.3M | ||
| Q4 24 | — | $-8.6M | ||
| Q3 24 | — | $-4.0M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $-7.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -12.1% | ||
| Q4 24 | — | -26.3% | ||
| Q3 24 | — | -16.3% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -21.8% |
| Q4 25 | — | — | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 15.5% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 13.9% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 17.8% |
| Q4 25 | 3.05× | — | ||
| Q3 25 | 0.70× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 52.24× | — | ||
| Q3 24 | 0.76× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.97× | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IVR
Segment breakdown not available.
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
